SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tonyt who wrote (670)9/9/1997 9:48:00 AM
From: Henry Niman   of 2173
 
Tony, You are still having a date and time problem. My first post on usenet regarding JNJ is

<<Subject:
Ligand (LGND ) & JNJ?
Date:
Wed, 03 Sep 1997 14:46:06 -0400
From:
"Henry L. Niman, Ph.D." <HNiman@worldnet.att.net>
Organization:
AT&T WorldNet Services
Newsgroups:
misc.invest.stocks

There is a rumor that LGND's diabetes partner will be JNJ. Investors
must like what they hear. LGND has moved to 15 3/4 on almost 400,000
shares so far. LGND presents at BioCentury tomorrow and Bear Stearns
next week.<<

As noted in the post, LGND had already traded 400,000 shares. The SI post
techstocks.com
was that morning at 8:58 BEFORE the open.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News